In terms of diagnosis, while there are no specific HDAC-based diagnostic tests for RA, advancements in biomarker research, such as the identification of epigenetic modifications associated with RA, hold promise for improving early detection and personalized treatment strategies for individuals with this debilitating condition. This evidence concerns the gene HDAC9 and rheumatoid arthritis.